Innovation for unmet patient needs: multinational pharmaceutical companies deliver value to Malaysia through clinical trials / June Choon Wai Yee
In the realm of medical innovation and patient care, Malaysia has achieved remarkable milestones in the clinical research landscape. As an invited delegate at the Clinical Trial Connect 2024 held on May 9 & 10, I witnessed the nation's impressive strides; a recordbreaking 276 newly sponsore...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Faculty of Pharmacy
2024
|
| Subjects: | |
| Online Access: | https://ir.uitm.edu.my/id/eprint/102546/1/102546.pdf https://ir.uitm.edu.my/id/eprint/102546/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | In the realm of medical innovation and patient care, Malaysia has achieved remarkable milestones in the clinical research landscape. As an invited delegate at the Clinical Trial Connect 2024 held on May 9 & 10, I witnessed the nation's impressive strides; a recordbreaking 276 newly sponsored clinical research studies brought in RM 1.16 billion in cumulative gross national income and created 2753 skilled jobs in clinical research since 2012. Surpassing its targets and previous years' accomplishments, Malaysia stands tall as a frontrunner in clinical trials within the Southeast Asia region, having secured second place in the number of global industry-sponsored studies. |
|---|